Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Neurology

What is the ALS Functional Rating Scale (ALSFRS-R)?

At a Glance

The ALSFRS-R is a 12-item questionnaire that measures physical function in ALS patients, with scores ranging from 0 to 48. Doctors focus on your rate of change over time, rather than a single score, to track disease progression and proactively plan for supportive care and assistive devices.

In this answer

2 sections

01

What Does the ALSFRS-R Measure?

02

Why the “Rate of Change” Matters Most

The ALS Functional Rating Scale-Revised (ALSFRS-R) is a 12-item questionnaire used by medical professionals to measure physical function and track disease progression in people with amyotrophic lateral sclerosis (ALS) [1]. It is usually administered by a nurse or doctor during a clinic visit, though sometimes patients self-report their scores through an app or online portal [2][3]. The total score ranges from 0 to 48, where a higher score indicates greater preserved physical ability [4]. Rather than focusing on a single number from one visit, doctors pay the most attention to your rate of change—how many points your score drops over weeks or months [5][6]. This rate of decline helps your care team understand your unique disease trajectory and anticipate when you might benefit from new supportive treatments to maintain your quality of life [7][8].

What Does the ALSFRS-R Measure?

The questionnaire evaluates twelve specific daily activities, which are grouped into four main functional categories [9]. You or your doctor will rate each activity on a scale from 0 to 4 [4]. A score of 4 means normal function. While a score of 0 indicates a total loss of function for that specific task, it is important to remember that this score is a signal for your medical team to provide supportive interventions—like mobility aids or communication devices—so you are never left helpless [8].

The four categories and their corresponding items are:

  • Bulbar Function (Head and Neck): Measures your ability to speak clearly, swallow food and liquids, and manage saliva [9].
  • Fine Motor Skills (Hands and Arms): Evaluates tasks requiring dexterity, including your ability to write, cut food, handle utensils, and manage dressing and personal hygiene [9]. (If you are experiencing slight weakness in your hands, you might notice your score in this section dropping slightly below a 4).
  • Gross Motor Skills (Legs and Torso): Assesses larger movements, including walking, climbing stairs, and turning over or adjusting blankets in bed [9].
  • Respiratory Function (Breathing): Checks for dyspnea (shortness of breath), orthopnea (shortness of breath when lying flat), and whether you need any external respiratory support or devices [9].

Why the “Rate of Change” Matters Most

ALS affects everyone differently, meaning there is no “normal” score [10]. Instead of comparing your score to others, your doctor uses your ALSFRS-R to compare you to your past self [5].

By calculating the rate of decline—often referred to as your “slope” or points lost per month—your medical team can better plan your future care [11][5]. On average, patients may see a decline of about 1 point per month, but individual progression varies widely [12]. Tracking this trajectory allows your team to proactively time interventions [7]. For example, if your bulbar subscore is dropping, they can intervene early with a feeding tube or communication device [8].

Nuances to Keep in Mind

  • Subscores vs. Total Score: Because the total score adds everything together, it can sometimes mask important changes in a specific area [4]. You might have a stable total score but be experiencing a decline in breathing. Doctors must look at the specific subscores, not just the total [13].
  • Plateaus Happen: While the score generally trends downward, progression is not perfectly smooth or linear [14]. Many patients experience plateaus where their score does not change for a time, or even minor score reversals [15][16].
  • Day-to-Day Fluctuations: It is completely normal to feel anxious about taking this test, as facing potential physical decline carries a heavy emotional weight. Try to avoid hyper-fixating on self-tracking every single day. Having a “bad day” where your hand feels extra weak does not mean your permanent “slope” has suddenly worsened.
  • Advanced Stages: In the later stages of ALS, the total ALSFRS-R score may become less useful for capturing your true quality of life, and doctors may rely on other specific measures [17].

Common questions in this guide

What is a normal ALSFRS-R score?
There is no single 'normal' score for ALS, as the disease affects everyone differently. The total score ranges from 0 to 48, with 48 representing full preserved physical function. Doctors focus on how your score changes over time rather than a single number.
What does the ALSFRS-R questionnaire measure?
The ALSFRS-R evaluates twelve daily activities grouped into four categories. These include bulbar function (speaking and swallowing), fine motor skills (using hands and arms), gross motor skills (walking and moving), and respiratory function (breathing).
Why is the rate of change in my ALSFRS-R score important?
Tracking how quickly your score changes helps your medical team understand your unique disease progression. This timeline allows doctors to proactively plan for supportive treatments, such as mobility aids or breathing support, before you urgently need them.
Can my ALSFRS-R score stay the same over time?
Yes, it is common to experience plateaus where your score remains stable for a period of time. While the general trend of the score decreases as the disease progresses, the decline is rarely perfectly smooth or linear.
Should I track my ALSFRS-R score at home?
While some patients use apps to self-report their scores, tracking daily can cause anxiety. If tracking your symptoms day-to-day negatively impacts your mental health, it is perfectly fine to let your clinic handle the assessments during your regular visits.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my current ALSFRS-R score, and how does it compare to my baseline?
  2. 2.Based on my rate of change, when should we start planning for assistive devices or respiratory support?
  3. 3.Can we look at my specific subscores to see which areas of my function are changing the fastest?
  4. 4.Would you recommend I track my score at home, or is it better for my mental health to just let the clinic handle it?
  5. 5.Are there any clinical trials available that are suited for my specific rate of progression?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can a Blood Test Diagnose ALS? NfL and Genetic TestsCan Cervical Spondylotic Myelopathy Be Misdiagnosed as ALS?Can You Live Longer Than 5 Years With ALS? Life ExpectancyHow Effective Are ALS Medications Riluzole & Edaravone?How to Manage ALS Muscle Cramps and SpasticityHow to Treat Excess Saliva (Sialorrhea) in ALSShould Family Members Get Genetic Testing for ALS?What Are the Benefits of an ALS Multidisciplinary Clinic?What Are the Benefits of Non-Invasive Ventilation in ALS?What Are the Stages of ALS Progression? King's & MiToSWhat Causes Uncontrollable Laughing and Crying in ALS?What to Expect During an EMG Test for ALSBulbar vs. Limb-Onset ALS: What Is the Difference?What Is the Difference Between PLS and ALS?When Should an ALS Patient Get a Feeding Tube?Who is Eligible for Qalsody (Tofersen) ALS Treatment?Why Was the ALS Drug Relyvrio Withdrawn from the Market?

References

References (17)
  1. 1

    Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale).

    Smith RA, Macklin EA, Myers KJ, et al.

    European journal of neurology 2018; (25(7)):907-e66 doi:10.1111/ene.13638.

    PMID: 29577526
  2. 2

    Self-assessment of amyotrophic lateral sclerosis functional rating scale on the patient's smartphone proves to be non-inferior to clinic data capture.

    Steinfurth L, Grehl T, Weyen U, et al.

    Amyotrophic lateral sclerosis & frontotemporal degeneration 2025; (26(5-6)):495-506 doi:10.1080/21678421.2025.2468404.

    PMID: 39985291
  3. 3

    Stay at home with the amyotrophic lateral sclerosis functional rating scale.

    McDermott CJ

    Journal of neurology, neurosurgery, and psychiatry 2020; (91(1)):7 doi:10.1136/jnnp-2019-321707.

    PMID: 31558652
  4. 4

    What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.

    Rooney J, Burke T, Vajda A, et al.

    Journal of neurology, neurosurgery, and psychiatry 2017; (88(5)):381-385 doi:10.1136/jnnp-2016-314661.

    PMID: 27888187
  5. 5

    Prognostic Factors and Epidemiology of Amyotrophic Lateral Sclerosis in Southeastern United States.

    Engelberg-Cook E, Shah JS, Teixeira da Silva Hucke A, et al.

    Mayo Clinic proceedings. Innovations, quality & outcomes 2024; (8(5)):482-492 doi:10.1016/j.mayocpiqo.2024.07.008.

    PMID: 39323877
  6. 6

    Natural history of the revised ALS functional rating scale and its association with survival: the PRECISION-ALS Extant Study.

    van Eijk RPA, Weemering DN, Opie-Martin S, et al.

    Amyotrophic lateral sclerosis & frontotemporal degeneration 2025; (26(sup1)):30-40 doi:10.1080/21678421.2024.2443985.

    PMID: 40326917
  7. 7

    Predictive modeling of ALS progression: an XGBoost approach using clinical features.

    Gupta R, Bhandari M, Grover A, et al.

    BioData mining 2024; (17(1)):54 doi:10.1186/s13040-024-00399-5.

    PMID: 39623504
  8. 8

    Variation in assistive technology use in Motor Neuron Disease according to clinical phenotypes and ALS Functional Rating Scale - Revised Score: A prospective observational study.

    Connors K, Mahony L, Morgan P

    NeuroRehabilitation 2019; (44(2)):303-313 doi:10.3233/NRE-182511.

    PMID: 31006691
  9. 9

    Assessing the Measurement Properties of the Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): A Rasch Analysis.

    Mehdipour A, Teshler L, Dal Bello-Haas V, et al.

    Physical therapy 2023; (103(11)) doi:10.1093/ptj/pzad109.

    PMID: 37581600
  10. 10

    Temporal stratification of amyotrophic lateral sclerosis patients using disease progression patterns.

    M Amaral D, Soares DF, Gromicho M, et al.

    Nature communications 2024; (15(1)):5717 doi:10.1038/s41467-024-49954-y.

    PMID: 38977678
  11. 11

    Associations between urate levels and amyotrophic lateral sclerosis functional score with edaravone treatment: Post hoc analysis of studies MCI186-16, MCI186-17, and MCI186-19.

    Takahashi F, Kano O, Nagano Y, et al.

    Muscle & nerve 2022; (66(5)):583-592 doi:10.1002/mus.27699.

    PMID: 36054038
  12. 12

    Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post-onset ΔFS for study design and medical practice.

    Ludolph AC, Corcia P, Desnuelle C, et al.

    Muscle & nerve 2024; (70(1)):36-41 doi:10.1002/mus.28101.

    PMID: 38712849
  13. 13

    An old friend who has overstayed their welcome: the ALSFRS-R total score as primary endpoint for ALS clinical trials.

    van Eijk RPA, de Jongh AD, Nikolakopoulos S, et al.

    Amyotrophic lateral sclerosis & frontotemporal degeneration 2021; (22(3-4)):300-307 doi:10.1080/21678421.2021.1879865.

    PMID: 33527843
  14. 14

    Clinimetrics: Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRS-R).

    Lee M, McCambridge A

    Journal of physiotherapy 2018; (64(4)):269-270 doi:10.1016/j.jphys.2018.07.005.

    PMID: 30193742
  15. 15

    Plateaus and reversals evaluated by different methods in patients with limb-onset amyotrophic lateral sclerosis.

    Hu N, Shen D, Yang X, et al.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2022; (97()):93-98 doi:10.1016/j.jocn.2022.01.016.

    PMID: 35074582
  16. 16

    The frequency of ALSFRS-R reversals and plateaus in patients with limb-onset amyotrophic lateral sclerosis: a cohort study.

    Hu N, Shen D, Yang X, et al.

    Acta neurologica Belgica 2022; (122(6)):1567-1573 doi:10.1007/s13760-021-01849-1.

    PMID: 35034333
  17. 17

    Evaluating ALSFRS-R as an indicator of disease milestones and functional independence: An observational study of US neurologists and their patients with amyotrophic lateral sclerosis.

    Mehdiyoun NF, Wright J, Robinson RL, et al.

    Journal of the neurological sciences 2026; (481()):125732 doi:10.1016/j.jns.2026.125732.

    PMID: 41520654

This page is for informational purposes only and does not replace professional medical advice. Always discuss your ALSFRS-R score and disease progression with your neurologist or ALS care team.

Get notified when new evidence is published on Amyotrophic lateral sclerosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.